Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix

Naren Gupta, Puttur D. Prasad, Sharad Ghamande, Pamela Moore-Martin, Anne V. Herdman, Robert G. Martindale, Robert Podolsky, Sela Mager, Malliga E. Ganapathy, Vadivel Ganapathy

Research output: Contribution to journalArticlepeer-review

87 Scopus citations


Objective. ATB0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB0,+ mRNA. ATB0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/ immunofluorescence. Results. ATB0,+ mRNA increased 5.6-fold (P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB0,+ protein. Conclusions. Expression of ATB0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.

Original languageEnglish (US)
Pages (from-to)8-13
Number of pages6
JournalGynecologic Oncology
Issue number1
StatePublished - Jan 2006


  • Amino acid transporter ATB
  • Arginine
  • Cervical cancer
  • Metastasis
  • Nitric oxide
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix'. Together they form a unique fingerprint.

Cite this